Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER , a Conserved Profibrogenic Long Noncoding RNA
Circulation · 29.08.2023 · 148 (9) · 778-797
DOI: 10.1161/circulationaha.122.062601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 29.08.2023. Verfasst von Parisa Aghagolzadeh und 12 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Cardiology Unit, Division of Cardiology, Department of Cardiovascular Medicine, University of Lausanne Medical School, Switzerland (P.A.…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Cardiomyopathies. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: British Heart Foundation, Department of Health.
Abstract (Originalsprache)
BACKGROUND: Cardiac fibroblasts have crucial roles in the heart. In particular, fibroblasts differentiate into myofibroblasts in the damaged myocardium, contributing to scar formation and interstitial fibrosis. Fibrosis is associated with heart dysfunction and failure. Myofibroblasts therefore represent attractive therapeutic targets. However, the lack of myofibroblast-specific markers has precluded the development of targeted therapies. In this context, most of the noncoding genome is transcribed into long noncoding RNAs (lncRNAs). A number of lncRNAs have pivotal functions in the cardiovascular system. lncRNAs are globally more cell-specific than protein-coding genes, supporting their importance as key determinants of cell identity. METHODS: In this study, we evaluated the value of the lncRNA transcriptome in very deep single-cell RNA sequencing. We profiled the lncRNA transcriptome in cardiac nonmyocyte cells after infarction and probed heterogeneity in the fibroblast and myofibroblast populations. In addition, we searched for subpopulation-specific markers that can constitute novel targets in therapy for heart disease. RESULTS: We demonstrated that cardiac cell identity can be defined by the sole expression of lncRNAs in single-cell experiments. In this analysis, we identified lncRNAs enriched in relevant myofibroblast subpopulations. Selecting 1 candidate we named FIXER (fibrogenic LOX -locus enhancer RNA), we showed that its silencing limits fibrosis and improves heart function after infarction. Mechanitically, FIXER interacts with CBX4, an E3 SUMO protein ligase and transcription factor, guiding CBX4 to the promoter of the transcription factor RUNX1 to control its expression and, consequently, the expression of a fibrogenic gene program.. FIXER is conserved in humans, supporting its translational value. CONCLUSIONS: Our results demonstrated that lncRNA expression is sufficient to identify the various cell types composing the mammalian heart. Focusing on cardiac fibroblasts and their derivatives, we identified lncRNAs uniquely expressed in myofibroblasts. In particular, the lncRNA FIXER represents a novel therapeutic target for cardiac fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Cardiology Unit, Division of Cardiology, Department of Cardiovascular Medicine, University of Lausanne Medical School, Switzerland (P.A., I.P., R.B., M.N., T.P.).
- Institute of Cardiovascular Sciences, University College London, United Kingdom (T.A.T.).
- Department for BioMedical Research, University of Bern, Switzerland (C.P.Q., P.C., R.J.).
- Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland (T.W.).
- Swiss Institute of Bioinformatics, Lausanne, Switzerland (T.W., L.W.).
- Cardiovascular Assessment Facility, University of Lausanne, Switzerland (A.S.).
ORCID-Profile: Riccardo Bernasconi, Thomas A Treibel, Carlos Pulido Quetglas, Tania Wyss, Leonore Wigger, Arantxa González, Thierry Pedrazzini
Förderung
- British Heart Foundation
- Department of Health
Zitieren
APA
Aghagolzadeh, P., Plaisance, I., Bernasconi, R., Treibel, T. A., Pulido Quetglas, C., Wyss, T., Wigger, L., Nemir, M., Sarre, A., Chouvardas, P., Johnson, R., González, A., & Pedrazzini, T. (2023). Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER , a Conserved Profibrogenic Long Noncoding RNA. Circulation, 148(9), 778-797. https://doi.org/10.1161/circulationaha.122.062601
Vancouver
Aghagolzadeh P, Plaisance I, Bernasconi R, Treibel TA, Pulido Quetglas C, Wyss T, et al. Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER , a Conserved Profibrogenic Long Noncoding RNA. Circulation. 2023;148(9):778-797. doi:10.1161/circulationaha.122.062601
BibTeX
@article{Aghagolzadeh2023,
author = {Aghagolzadeh, Parisa and Plaisance, Isabelle and Bernasconi, Riccardo and Treibel, Thomas A and Pulido Quetglas, Carlos and Wyss, Tania and Wigger, Leonore and Nemir, Mohamed and Sarre, Alexandre and Chouvardas, Panagiotis and Johnson, Rory and González, Arantxa and Pedrazzini, Thierry},
title = {Assessment of the Cardiac Noncoding Transcriptome by Single-Cell RNA Sequencing Identifies FIXER , a Conserved Profibrogenic Long Noncoding RNA},
journal = {Circulation},
year = {2023},
volume = {148},
number = {9},
pages = {778--797},
doi = {10.1161/circulationaha.122.062601}
}
EUVIMED